Global Health Limited reports Q1 FY27 results and appoints Chief Digital Officer
Global Health · Healthcare Services
Key highlights
- Consolidated revenue from operations for the quarter ended June 30, 2026 was ₹13,040.51 million.
- Consolidated profit after tax for the quarter ended June 30, 2026 was ₹1,572.52 million.
- Record date August 14, 2026 for final dividend of ₹0.50 per equity share for FY 2025-26, subject to AGM approval on September 16, 2026.
Why it's rated notable: the amount is 21% of annual revenue (20% to 50%)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulations.
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Global Health
- Capex / expansionNotableGlobal Health (Medanta) Q2 FY27 revenue up 33.6%; 500-bed Ghaziabad hospital approved
- Dividend / buyback / bonusNotableGlobal Health Ltd announces Q1 FY 2026-27 financial results and management changes
- Capex / expansionNotableGlobal Health Limited announces Q1 FY 2026-27 financial results and new appointment
- Capex / expansionNotableGlobal Health Ltd Q1 results; Chief Digital Officer named; Guwahati beds to 650
- Financial resultsNotableGlobal Health: FY26 results approved, ₹0.50 dividend recommended, two SMPs named
Other dividend / buyback / bonus filings this fortnight
- Premco Global Ltd approves Q2 FY 2026-27 results, declares interim dividend, appoints auditor
- Precision Wires India board approves Sept 2026 quarter results and 35% dividend
- Dynamatic Technologies announces Q2 FY27 financial results and interim dividend
- Great Eastern Shipping approves Q2 and H1 results; declares Rs 14.40 interim dividend
- Safari Industries (India) Limited approves Q2 & H1 FY27 results, interim dividend, capex
- IRB Infrastructure Developers announces Q2 & H1 FY27 results and 2nd interim dividend
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM QualityGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.